Camille L Bedrosian - Net Worth and Insider Trading
Camille L Bedrosian Net Worth
The estimated net worth of Camille L Bedrosian is at least $2 Million dollars as of 2024-05-15. Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $2 Million. Details can be seen in Camille L Bedrosian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Camille L Bedrosian has not made any transactions after 2023-03-01 and currently still holds the listed stock(s).
Transaction Summary of Camille L Bedrosian
Camille L Bedrosian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Camille L Bedrosian owns 4 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .
Click here to see the complete history of Camille L Bedrosian’s form 4 insider trades.
Insider Ownership Summary of Camille L Bedrosian
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | EVP and Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals Inc | 2020-09-01 | director |
ARIA | ARIAD Pharmaceuticals Inc | 2007-04-16 | VP & Chief Medical Officer |
2020-12-09 | director |
Camille L Bedrosian Latest Holdings Summary
Camille L Bedrosian currently owns a total of 1 stock. Camille L Bedrosian owns 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2023, with a value of $2 Million.
Latest Holdings of Camille L Bedrosian
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | 46,720 | 40.97 | 1,914,118 |
Holding Weightings of Camille L Bedrosian
Camille L Bedrosian Form 4 Trading Tracker
According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 11 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 3,881 shares on March 1, 2023, which brought Camille L Bedrosian around $175,615.
Insider Trading History of Camille L Bedrosian
- 1
Camille L Bedrosian Trading Performance
Camille L Bedrosian Ownership Network
Ownership Network List of Camille L Bedrosian
Ownership Network Relation of Camille L Bedrosian
Camille L Bedrosian Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Camille L Bedrosian made 1 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 3,881. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .
In summary, during the past 3 months, insiders sold 39,487 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 39,487 shares. During the past 18 months, 243,647 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,647 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Camille L Bedrosian Mailing Address
Above is the net worth, insider trading, and ownership report for Camille L Bedrosian. You might contact Camille L Bedrosian via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.